Patterns of Acquired Bleeding Disorders in a Tertiary Care Hospital

被引:7
作者
Asthana, Bhushan [1 ]
Sharma, Prashant [1 ]
Ranjan, Ravi [1 ]
Jain, Prachi [1 ]
Aravindan, Ajisha [1 ]
Mishra, Pravas Chandra [1 ]
Saxena, Renu [1 ]
机构
[1] All India Inst Med Sci, Dept Haematol, New Delhi 110029, India
关键词
acquired bleeding disorders; DIC; hepatic coagulopathy; isolated prolonged prothrombin time; factor inhibitors; hemostasis; anticoagulants; FROZEN PLASMA TRANSFUSION; TIME;
D O I
10.1177/1076029609334123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bleeding disorders constitute a large proportion of referrals to hematology departments. Worldwide, acquired causes of bleeding are commoner than inherited ones. To identify the spectrum of these disorders, we evaluated all referrals for bleeding encountered in this tertiary care centre over a one-year period. OF the total 1342 cases, 1040 (77.5%) had underlying exclusively acquired causes, whereas inherited causes constituted 302 cases (22.5%). Amongst acquired causes, disseminated intravascular coagulation was seen in 297 (28.6%), hepatic coagulopathy in 218 (20.9%), neurosurgical Causes (intracranial bleeds) in 154 (14.8%), malignancy in 89 (8.6%), and miscellaneous multiple acquired causes including those due to anticoagulant drug overdose in 282 patients (27.1%). Referrals for isolated prolonged prothrombin time or thrombocytopenia were common, but were excluded from this study because not all presented with bleeding. Prompt laboratory work-Up and precise identification of acquired causes of bleeding is the key to planning appropriate patient management including transfusion Support.
引用
收藏
页码:448 / 453
页数:6
相关论文
共 27 条
[1]   Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities [J].
Abdel-Wahab, Omar I. ;
Healy, Brian ;
Dzik, Walter H. .
TRANSFUSION, 2006, 46 (08) :1279-1285
[2]   ACQUIRED PLATELET-FUNCTION DEFECTS [J].
BICK, RL .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (06) :1203-1228
[3]   A new device for measurement of fibrin clot lysis: Application to the Euglobulin Clot Lysis Time [J].
Zouaoui Boudjeltia K. ;
Cauchie Ph. ;
Remacle Cl. ;
Guillaume M. ;
Brohée D. ;
Hubert J.L. ;
Vanhaeverbeek M. .
BMC Biotechnology, 2 (1)
[4]  
*BRIT COMM STAND H, 1998, BRIT J HAEMATOL, V101, P374
[5]  
Dacie J. V., 2001, PRACTICAL HAEMATOLOG, V9, P633
[6]   Interpretation of the international normalised ratio in patients with liver disease [J].
Deitcher, SR .
LANCET, 2002, 359 (9300) :47-48
[7]  
FEINSTEIN RJ, 1973, ARCH DERMATOL, V108, P229, DOI 10.1001/archderm.108.2.229
[8]   Comparison of five thrombin time reagents [J].
Flanders, MM ;
Crist, R ;
Rodgers, GM .
CLINICAL CHEMISTRY, 2003, 49 (01) :169-172
[9]   Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety [J].
Hirsh, J ;
Warkentin, TE ;
Raschke, R ;
Granger, C ;
Ohman, EM ;
Dalen, JE .
CHEST, 1998, 114 (05) :489S-510S
[10]   Toward rational fresh frozen plasma transfusion - The effect of plasma transfusion on coagulation test results [J].
Holland, Lorne L. ;
Brooks, Jay P. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (01) :133-139